Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes

Pieter Pannus, Kristof Y Neven, Stéphane De Craeye, Leo Heyndrickx, Sara Vande Kerckhove, Daphnée Georges, Johan Michiels, Antoine Francotte, Marc Van Den Bulcke, Maan Zrein, Steven Van Gucht, Marie-Noëlle Schmickler, Mathieu Verbrugghe, André Matagne, Isabelle Thomas, Katelijne Dierick, Joshua A. Weiner, Margaret E. Ackerman, Stanislas Goriely, Maria E Goossens, Kevin K. Ariën, Isabelle Desombere, Arnaud Marchant
doi: https://doi.org/10.1101/2021.06.08.21258366

Article Information

doi 
https://doi.org/10.1101/2021.06.08.21258366
History 
  • June 9, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Pieter Pannus, Ph.D.1,¥,‡,
  2. Kristof Y Neven, Ph.D.1,¥,
  3. Stéphane De Craeye, Ph.D.2,
  4. Leo Heyndrickx, M.Sc.3,
  5. Sara Vande Kerckhove, M.Sc.2,
  6. Daphnée Georges, M.Sc.4,5,
  7. Johan Michiels, B.Sc.3,
  8. Antoine Francotte, M.Sc.2,
  9. Marc Van Den Bulcke, Ph.D.1,
  10. Maan Zrein, PhD6,
  11. Steven Van Gucht, Ph.D.2,
  12. Marie-Noëlle Schmickler, M.D.7,
  13. Mathieu Verbrugghe, Ph.D.7,
  14. André Matagne, Ph.D.5,
  15. Isabelle Thomas, Ph.D.2,
  16. Katelijne Dierick, D.M.V.2,
  17. Joshua A. Weiner, Ph.D.8,
  18. Margaret E. Ackerman, Ph.D.8,
  19. Stanislas Goriely, M.D.4,
  20. Maria E Goossens, M.D.1,*,
  21. Kevin K. Ariën, Ph.D.3,9,*,
  22. Isabelle Desombere, Ph.D.2,* and
  23. Arnaud Marchant, M.D.4,*,†
  1. 1SD Epidemiology and Public Health, Sciensano, Anderlecht, Belgium
  2. 2SD Infectious Diseases in Humans, Sciensano, Ukkel, Belgium
  3. 3Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
  4. 4Institute for Medical Immunology and ULB Center for Research in Immunology (U-CRI), Université libre de Bruxelles (ULB), Gosselies, Belgium
  5. 5Laboratory of Enzymology and Protein Folding, Centre for Protein Engineering, InBioS, University of Liège, Liège, Belgium
  6. 6InfYnity Biomarkers, Lyon, France
  7. 7Mensura EDPB, Occupational Health Service, Antwerp, Belgium
  8. 8Thayer School of Engineering, Dartmouth College, Hanover, NH 03755 USA
  9. 9Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
  1. ↵†Corresponding author:
    Arnaud Marchant, Institute for Medical Immunology, Campus Erasme, 808 Route de Lennik, 1070 Bruxelles, Belgium. Email: arnaud.marchant{at}ulb.be
  2. ↵‡Alternate corresponding author:
    Pieter Pannus, SD Epidemiology and Public Health, Sciensano, 1 Blerotstraat, 1070 Anderlecht, Belgium. Email: pieter.pannus{at}sciensano.be

  1. ↵¥ P. P. and K. Y. N. contributed equally to this article.

  2. ↵* M.E.G., K.K.A., I.D. and A.M. contributed equally to this article.

Back to top
Posted June 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes
Pieter Pannus, Kristof Y Neven, Stéphane De Craeye, Leo Heyndrickx, Sara Vande Kerckhove, Daphnée Georges, Johan Michiels, Antoine Francotte, Marc Van Den Bulcke, Maan Zrein, Steven Van Gucht, Marie-Noëlle Schmickler, Mathieu Verbrugghe, André Matagne, Isabelle Thomas, Katelijne Dierick, Joshua A. Weiner, Margaret E. Ackerman, Stanislas Goriely, Maria E Goossens, Kevin K. Ariën, Isabelle Desombere, Arnaud Marchant
medRxiv 2021.06.08.21258366; doi: https://doi.org/10.1101/2021.06.08.21258366
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area